
Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00.
Shares of Evolent Health are trading down 2.43% over the last 24 hours, at $27.84 per share.

Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00.
Shares of Evolent Health are trading down 2.43% over the last 24 hours, at $27.84 per share.